Subscribe to Newsletter
Business & Profession Professional Development

A Whole New World… of Regulatory Approvals

The European Union’s Medical Device Directives are getting an overhaul – and companies must adapt to survive

Business & Profession Imaging & Diagnostics

The Eye Exam's Quantum Leap

| Pearse Keane, Alex Walsh

A future of skyrocketing patient numbers in the clinic and technological advances means that the routine eye exam of tomorrow has to be substantially different. But how?

Business & Profession Professional Development

The Cyberman’s Apprentice

Sitting Down With... John Marshall, Frost Professor of Ophthalmology, Institute of Ophthalmology, University College London, UK.

Subspecialties Glaucoma

A Story of Graphene, Gold, Tear Film and Ocular Injury

| Roisin McGuigan

Ascorbic acid testing could provide fast information on the severity of ocular injuries and postsurgical complications at the point-of-care

Subspecialties Cataract

Accommodating Accommodating IOLs

| Michael Schubert

Patients with myopia often get poorer results from accommodating IOLs than those without – and a recent study explains why

Subspecialties Basic & Translational Research

RGCs from the FACS machine

| Michael Schubert, Mark Hillen

For retina stem cell researchers, growing and purifying lots of RGCs from hPSCs has been hard… until now

Subspecialties Basic & Translational Research

Drugs From the Deep

| Michael Schubert

Marine mammals have tear films filled with interesting antimicrobial agents – and understanding the compounds present might one day lead to new antibiotic drugs

Subspecialties Neuro-ophthalmology

The Nature of Neuromyelitis Optica

| Michael Schubert

A retrospective study by the Neuromyelitis Optica Study Group helps physicians better understand the challenging disease

Subspecialties Retina

Running on Empty

| Mark Hillen

Photoreceptors – and the retina in general – are highly metabolically active. But their maxed-out mitochondria can’t give much more. And when even small metabolic imbalances arise…

Subspecialties Cornea / Ocular Surface

OSD Overhaul

| Roisin McGuigan, Mark Hillen

Three new pipeline therapies may offer relief to patients with ocular surface disease

Register to The Ophthalmologist

Register to access our FREE online portfolio, request the magazine in print and manage your preferences.

You will benefit from:
  • Unlimited access to ALL articles
  • News, interviews & opinions from leading industry experts
  • Receive print (and PDF) copies of The Ophthalmologist magazine

Register

Disclaimer

The Ophthalmologist website is intended solely for the eyes of healthcare professionals. Please confirm below: